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Flavone acetic acid (FAA) differs from other chemothera-
peutic agents in its broad spectrum of activity against experi-
mental solid tumours (Hill et al., 1989), and in causing rapid
tumour necrosis (Smith et al., 1987). Tumour blood flow falls
early and accounts for a major component of cell killing (Zwi
et al., 1989). FAA also stimulates cytotoxicity against tumour
cells by immune effector cells (Ching & Baguley 1989a), but
the relationship of the immune effects to the blood flow effect
is not understood. The toxicity of FAA also differs from that
of conventional agents: hypotension and diarrhoea rather
than myelosuppression and alopecia are the major toxic
effects observed in patients (Kerr et al., 1989). In mice, the
lethal effects of FAA are usually seen within 24h and are
preceded by a drop in body temperature (Hill et al., 1989),
but the nature of the toxic action is unknown.
Necrosis, a characteristic effect of FAA in tumours, has
not previously been reported in non-tumour tissues. We
therefore examined, by conventional histology, normal and
tumour tissues from mice treated with therapeutic doses of
FAA or its more potent analogue 5,6-dimethyl xanthenone
acetic acid (DMXAA) (Baguley et al., 1990). Necrosis was
found not only in tumours but also in peripheral lymphoid
tissues, the thymus gland and the uterus. These sensitive
normal tissues have in common with tumours a low vascular
density as shown by the distribution of fluorescent perfusion
markers.
Hybrid (C52BL/6JxDBA/2J)F, (BDFI) mice with or with-
out subcutaneous Colon 38 tumours (0.4-1.2 g) were treated
with intravenous (i.v.) FAA or DMXAA dissolved in 5%
w/v sodium bicarbonate. Balb/C mice bearing intraperitoneal
(i.p.) EMT6 spheroids were treated with FAA i.v. or i.p., as
described previously (Zwi et al., 1990). Tumour and non-
tumour tissues were excised, fixed in 4% formaldehyde,
embedded in paraffin, stained with haematoxylin and eosin
and examined by light microscopy.
Necrosis, identified as confluent areas of nuclear fragmen-
tation, dissolution or pyknosis as well as cytoplasmic frag-
mentation, was extensive in all FAA-treated tumours, and
was often accompanied by haemorrhage. The earliest his-
tological changes were evident by 4 h, and between 8 h and
24 h necrotic and unaffected tumour tissue were clearly dis-
tinguished. Small areas of necrosis were sometimes seen in
untreated tumours, but the appearances differed from drug-
induced necrosis. The former type appeared to have accumu-
lated over time, and the necrotic material furthest from the
viable tissues showed the greatest degree of nuclear break-
down. Drug-induced necrososis was more uniform and less
advanced, as described previously in spheroids (Zwi et al.,
1990).
Necrosis was also seen in lymphoid tissues and in the
uterus of FAA-treated mice by 8 h (but rarely at 4 h). The
frequency with these tissues were affected in the various
experiments is summarised in Table I. In peripheral lymphoid
tissues, FAA-induced necrosis occurred in the B-cell follicles,
while the surrounding T-cell parafollicular zones remained
viable (Figure la). In any individual mouse, the lymphoid
follicles of a particular tissue were all equally affected, but
different organs showed different sensitivities. Gut lymphoid
nodules (Peyer's patches) were more frequently affected than
lymph nodes or the white pulp of the spleen. FAA also
induced necrosis of the entire cortex of the thymus glands of
some tumour-bearing mice, though the medulla was spared
in each case. The uterine changes varied from focal
superficial endometrial necrosis to extensive necrosis involv-
ing myometrium (Figure lb). Thrombi were invariably pres-
ent in peripheral lymphoid tissues associated with necrosis,
but were only occasionally found in treated tumours.
Thrombi were not seen in the uterus or thymus. Other tissues
examined included non-lymphoid gut, liver, pancreas, testis,
ovary, fat, skeletal muscle, lung, adrenal, kidney and bone
marrow, but these did not show necrosis, thrombosis,
haemorrage or any other histological change.
DMXAA-treated mice showed necrotic changes within all
tumours. Peripheral lymphoid organs also showed necrosis,
differing in pattern from that following FAA. In affected
tissues several small scattered foci of necrosis, none greater
than five cell diameters, were seen not only in lymphoid
follicles, but also in the parafollicular zone. In the follicles
the necrotic foci corresponded in distribution to that of
tingible body macrophages, seen in lymphoid tissues of un-
treated mice (and those of humans). Accompanying throm-
bosis or haemorrhage were not seen.
The functional vessels of tumour and non-tumour tissues
in untreated mice were demonstrated by fluorescence micro-
scopy on frozen sections, as described previously (Zwi et al.,
1990). Briefly, a single injection (0.0Iml g' body weight)
containing Hoechst 33342 (H33342) 3.25mM and 10-nonyl
acridine orange (NAO) 2 mM in 5% w/v D-glucose and 4%
dimethylsulphoxide, was given five minutes before killing and
the tumours and normal tissues were excised, frozen and
sectioned.
Both fluorescent dyes showed restricted diffusion into the
cells of peripheral lymphoid tissues (Figure 2), the thymus,
and the deeper layer of the endometrium, due to wide inter-
capillary distances. This pattern was similar to that seen in
the tumours in this study and in earlier studies (Trotter et al.,
1989; Zwi et al., 1990). Other tissues including non-lymphoid
gut tissue (Figure 2), pancreas, liver, kidney, adrenal, fat and
muscle showed confluent tissue staining.
The occurrence of necrosis in certain non-tumour tissues
provides an additional perspective on the basis of tissue
selectivity of FAA. Tumours and lymphoid tissues both con-
tain large numbers of immune effector cells including mac-
rophages and NK-cells (Ching & Baguley, 1989b), and FAA
increases the cytolytic activity of such cells (Ching & Bag-
uley, 1988, 1989a). Neutrophils are present in large numbers
in the superficial endometrium, and if these cells respond to
FAA, this might explain the sensitivity of the uterus to
necrosis. Neutrophils have been implicated in uterine necrosis
following toxic doses of tumour necrosis factor-a (TNF)
(Shalaby et al., 1989). These authors also noted focal cell
lysis in lymphoid follicles and the thymus.
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Table I Distribution of necrosis
Dose Time
Mice Tumour Drug (mmolkg-') (h) na Gut lymphoid nodule Lymph node Spleen Thymus Uterus Tumour
Balb/C EMT6 FAA 0.8 18 7 4/6b 0/2 1/5 7/7
BDF, Co38 FAA 1.2 8-24 19 14/14 6/10 8/17 3/4 7/7 19/19
BDF, none FAA 1.2 24 4 4/4 3/3 1/4 0/4 2/3
BDF1 Co38 DMXAA 0.065 8-24 8 4/8 1/3 3/4 8/8
Both strains, tumours; untreated 10 0/7 0/4 0/4 0/4 0/4 0/10
aNumber ofmice, bFraction ofmice in which the tissue showed drug-induced necrosis. Between I and 6 (mode = 2) gut lymphoid nodules, and
between I and 3 (mode = 1) lymph nodes were examined from each mouse.
Alternatively, the critical common factor could be the low
vascular densities seen in all affected tissues types. This could
cause relatively poor exchange between tissue and circulation,
resulting in hypoxia and a low extracellular pH (Vaupel et
al., 1981). The latter could lead to increased intracellular
concentrations of FAA as it is weak acid (Denny & Wilson,
1986). Hypoxia stimulates the production of a macrophage
angiogenic factor (Knighton et al., 1983), which is presum-
ably TNF (Leibovich et al., 1987). FAA also stimulates the
production of TNF (Mace et al., 1990), and could thus
synergise with the hypoxic stimulus to release this monokine
in cytotoxic quantities. The large intercapillary distances
could retard the clearance of cytotoxic substances produced
in the tissues in response to FAA.
b I
Figure I Histology of non-tumour tissues after FAA treatment.
a, Small bowel lymphoid nodule showing necrosis of the B-cell
follicle (B) with sparing of the T-cell zone (T). A thrombosed
vessel is indicated (arrowheads). Ulceration of the epithelium
(arrow) was not a common finding. b, Uterus showing necrosis of
the endometrium (arrowheads), extending into the myometrium
(arrow). Bars = 100iLm.
While perfusion failure plays an important causal role in
tumour necrosis (Zwi et al., 1989), this may not apply to
lymphoid tissue necrosis. Injecting H33342 together with
FAA i.v., and NAO 4 h later (according to Zwi et al., 1990),
we failed to demonstrate loss of flow in peripheral lymphoid
tissues (results not shown). By this time small haemorrhages
(indicating early tissue damage) were visible macroscopically
in gut lymphoid nodules. This suggests that perfusion failure
follows rather than precedes tissue damage in peripheral
lymphoid tissue. Coagulation abnormalities occur early after
FAA treatment (Murray et al., 1989) and may predispose to
the thrombosis seen in affected tissues after FAA treatment.
However, the absence of thrombi from peripheral lymphoid
Figure 2 Fluorescent staining of small bowel tissues (without
FAA treatment). Fluorescence is limited to paravascular cells by
low vascular density in the T-cell zone (T) and the B-cell zone (B)
of the lymphoid nodule. In mucosal glands (G) all cells fluoresce
indicating a high vessel density. a, H33342 stains nuclei, and b,
NAO stains cytoplasm. Both dyes were injected 5min before
killing. Air-dried frozen sections were viewed with Nikon Opti-
phot filter blocks UVIA (a) and B2A (b). Bar=40plm.934 L.J. ZWI et al.
tissues after DMXAA treatment, and from the thymus
glands and uteri of FAA-treated mice, suggests that throm-
bosis is secondary.
In conclusion, the recognition of necrosis and thrombosis
in non-tumour tissues at therapeutic doses indicates that the
necrotising action of FAA and DMXAA is not entirely
specific for tumour tissues. The normal tissue necrosis ob-
served is unlikely to explain directly the lethal effects in mice,
since damage to lymphoid organs should not cause immed-
iate compromise of vital functions. However, if such necrosis
occurs in humans, immune function could be affected. Endo-
metrial necrosis may have contributed to the vaginal bleeding
seen in one patient who became thrombocytopaenic after
FAA treatment (Kerr et al., 1989). In our experiments, tissue
sensitivity was similar to that seen after TNF (Shalably et al.,
1989), further evidence of TNF involvement in the actions of
FAA. The distribution of the necrotic lesions suggests var-
ious determinants of tissue selectivity, including concentra-
tions of immune effector cells and low vascular density.
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